메뉴 건너뛰기




Volumn 36, Issue 3, 2015, Pages 767-775

Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model

Author keywords

GW501516; Insulin resistance enzymes related to lipid metabolism; Non alcoholic fatty liver disease; Peroxisome proliferator activated receptor

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; FATTY ACID; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLUCOSE TRANSPORTER 2; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PIOGLITAZONE; SOMATOMEDIN C; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; THIAZOLE DERIVATIVE;

EID: 84938098177     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2270     Document Type: Article
Times cited : (15)

References (52)
  • 2
    • 0036829092 scopus 로고    scopus 로고
    • AGA technical review on nonalcoholic fatty liver disease
    • American Gastroenterological Association
    • Sanyal AJ; American Gastroenterological Association: AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123: 1705-1725, 2002.
    • (2002) Gastroenterology , vol.123 , pp. 1705-1725
    • Sanyal, A.J.1
  • 5
    • 84877854022 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
    • Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E and Gastaldelli A: Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5: 1544-1560, 2013.
    • (2013) Nutrients , vol.5 , pp. 1544-1560
    • Gaggini, M.1    Morelli, M.2    Buzzigoli, E.3    DeFronzo, R.A.4    Bugianesi, E.5    Gastaldelli, A.6
  • 6
    • 78650486196 scopus 로고    scopus 로고
    • Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study
    • Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL and Harrison SA: Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140: 124-131, 2011.
    • (2011) Gastroenterology , vol.140 , pp. 124-131
    • Williams, C.D.1    Stengel, J.2    Asike, M.I.3    Torres, D.M.4    Shaw, J.5    Contreras, M.6    Landt, C.L.7    Harrison, S.A.8
  • 7
    • 77952563455 scopus 로고    scopus 로고
    • Liver fat in the pathogenesis of insulin resistance and type 2 diabetes
    • Yki-Jarvinen H: Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig Dis 28: 203-209, 2010.
    • (2010) Dig Dis , vol.28 , pp. 203-209
    • Yki-Jarvinen, H.1
  • 9
    • 25644448266 scopus 로고    scopus 로고
    • Fat in the liver and insulin resistance
    • Yki-Jarvinen H: Fat in the liver and insulin resistance. Ann Med 37: 347-356, 2005.
    • (2005) Ann Med , vol.37 , pp. 347-356
    • Yki-Jarvinen, H.1
  • 10
    • 0033305213 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptors: Nuclear control of metabolism
    • Desvergne B and Wahli W: Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20: 649-688, 1999.
    • (1999) Endocr Rev , vol.20 , pp. 649-688
    • Desvergne, B.1    Wahli, W.2
  • 11
    • 0032489437 scopus 로고    scopus 로고
    • Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)
    • Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T and Gonzalez FJ: Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 273: 5678-5684, 1998.
    • (1998) J Biol Chem , vol.273 , pp. 5678-5684
    • Aoyama, T.1    Peters, J.M.2    Iritani, N.3    Nakajima, T.4    Furihata, K.5    Hashimoto, T.6    Gonzalez, F.J.7
  • 13
    • 0033594980 scopus 로고    scopus 로고
    • A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: The PPARalpha-null mouse as a model of fatty acid oxidation disorders
    • Leone TC, Weinheimer CJ and Kelly DP: A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 96: 7473-7478, 1999.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 7473-7478
    • Leone, T.C.1    Weinheimer, C.J.2    Kelly, D.P.3
  • 14
    • 0028641559 scopus 로고
    • Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
    • Tontonoz P, Hu E and Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79: 1147-1156, 1994.
    • (1994) Cell , vol.79 , pp. 1147-1156
    • Tontonoz, P.1    Hu, E.2    Spiegelman, B.M.3
  • 15
    • 0037330414 scopus 로고    scopus 로고
    • PPARgamma agonists in the treatment of type II diabetes: Is increased fatness commensurate with long-term efficacy?
    • Larsen TM, Toubro S and Astrup A: PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes Relat Metab Disord 27: 147-161, 2003.
    • (2003) Int J Obes Relat Metab Disord , vol.27 , pp. 147-161
    • Larsen, T.M.1    Toubro, S.2    Astrup, A.3
  • 17
    • 0033851704 scopus 로고    scopus 로고
    • Pioglitazone
    • Gillies PS and Dunn CJ: Pioglitazone. Drugs 60: 333-345, 2000.
    • (2000) Drugs , vol.60 , pp. 333-345
    • Gillies, P.S.1    Dunn, C.J.2
  • 18
    • 0034804726 scopus 로고    scopus 로고
    • Pioglitazone: Mechanism of action
    • Smith U: Pioglitazone: mechanism of action. Int J Clin Pract Suppl: 13-18, 2001.
    • (2001) Int J Clin Pract Suppl , vol.13-18
    • Smith, U.1
  • 19
    • 0033542873 scopus 로고    scopus 로고
    • Medical significance of peroxisome proliferator-activated receptors
    • Vamecq J and Latruffe N: Medical significance of peroxisome proliferator-activated receptors. Lancet 354: 141-148, 1999.
    • (1999) Lancet , vol.354 , pp. 141-148
    • Vamecq, J.1    Latruffe, N.2
  • 20
    • 0141532275 scopus 로고    scopus 로고
    • Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone
    • Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D and Bacon BR: Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology 38: 1008-1017, 2003.
    • (2003) Hepatology , vol.38 , pp. 1008-1017
    • Neuschwander-Tetri, B.A.1    Brunt, E.M.2    Wehmeier, K.R.3    Oliver, D.4    Bacon, B.R.5
  • 21
    • 84891922735 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor gamma regulates genes involved in insulin/insulin-like growth factor signaling and lipid metabolism during adipogenesis through functionally distinct enhancer classes
    • Oger F, Dubois-Chevalier J, Gheeraert C, Avner S, Durand E, Froguel P, Salbert G, Staels B, Lefebvre P and Eeckhoute J: Peroxisome proliferator-activated receptor gamma regulates genes involved in insulin/insulin-like growth factor signaling and lipid metabolism during adipogenesis through functionally distinct enhancer classes. J Biol Chem 289: 708-722, 2014.
    • (2014) J Biol Chem , vol.289 , pp. 708-722
    • Oger, F.1    Dubois-Chevalier, J.2    Gheeraert, C.3    Avner, S.4    Durand, E.5    Froguel, P.6    Salbert, G.7    Staels, B.8    Lefebvre, P.9    Eeckhoute, J.10
  • 22
    • 77950202392 scopus 로고    scopus 로고
    • Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells
    • Coll T, Alvarez-Guardia D, Barroso E, Gómez-Foix AM, Palomer X, Laguna JC and Vázquez-Carrera M: Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells. Endocrinology 151: 1560-1569, 2010.
    • (2010) Endocrinology , vol.151 , pp. 1560-1569
    • Coll, T.1    Alvarez-Guardia, D.2    Barroso, E.3    Gómez-Foix, A.M.4    Palomer, X.5    Laguna, J.C.6    Vázquez-Carrera, M.7
  • 23
    • 79955368052 scopus 로고    scopus 로고
    • The PPARbeta/delta activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1alpha-Lipin 1-PPARalpha pathway leading to increased fatty acid oxidation
    • Barroso E, Rodriguez-Calvo R, Serrano-Marco L, Astudillo AM, Balsinde J, Palomer X and Vázquez-Carrera M: The PPARbeta/delta activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1alpha-Lipin 1-PPARalpha pathway leading to increased fatty acid oxidation. Endocrinology 152: 1848-1859, 2011.
    • (2011) Endocrinology , vol.152 , pp. 1848-1859
    • Barroso, E.1    Rodriguez-Calvo, R.2    Serrano-Marco, L.3    Astudillo, A.M.4    Balsinde, J.5    Palomer, X.6    Vázquez-Carrera, M.7
  • 24
    • 84856705923 scopus 로고    scopus 로고
    • The peroxisome proliferator-activated receptor (PPAR) beta/delta agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells
    • Serrano-Marco L, Barroso E, El Kochairi I, Palomer X, Michalik L, Wahli W and Vázquez-Carrera M: The peroxisome proliferator-activated receptor (PPAR) beta/delta agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells. Diabetologia 55: 743-751, 2012.
    • (2012) Diabetologia , vol.55 , pp. 743-751
    • Serrano-Marco, L.1    Barroso, E.2    El Kochairi, I.3    Palomer, X.4    Michalik, L.5    Wahli, W.6    Vázquez-Carrera, M.7
  • 25
    • 33645891166 scopus 로고    scopus 로고
    • Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet
    • Nagasawa T, Inada Y, Nakano S, Tamura T, Takahashi T, Maruyama K, Yamazaki Y, Kuroda J and Shibata N: Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet. Eur J Pharmacol 536: 182-191, 2006.
    • (2006) Eur J Pharmacol , vol.536 , pp. 182-191
    • Nagasawa, T.1    Inada, Y.2    Nakano, S.3    Tamura, T.4    Takahashi, T.5    Maruyama, K.6    Yamazaki, Y.7    Kuroda, J.8    Shibata, N.9
  • 26
    • 0021813187 scopus 로고
    • Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
    • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
    • (1985) Diabetologia , vol.28 , pp. 412-419
    • Matthews, D.R.1    Hosker, J.P.2    Rudenski, A.S.3    Naylor, B.A.4    Treacher, D.F.5    Turner, R.C.6
  • 27
    • 63449137682 scopus 로고    scopus 로고
    • Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease
    • Wang HN, Wang YR, Liu GQ, Liu Z, Wu PX, Wei XL and Hong TP: Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease. World J Gastroenterol 14: 7240-7246, 2008.
    • (2008) World J Gastroenterol , vol.14 , pp. 7240-7246
    • Wang, H.N.1    Wang, Y.R.2    Liu, G.Q.3    Liu, Z.4    Wu, P.X.5    Wei, X.L.6    Hong, T.P.7
  • 28
    • 0035710746 scopus 로고    scopus 로고
    • Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
    • Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
    • (2001) Methods , vol.25 , pp. 402-408
    • Livak, K.J.1    Schmittgen, T.D.2
  • 29
    • 77957302090 scopus 로고    scopus 로고
    • Hepatic steatosis: A role for de novo lipogenesis and the transcription factor SREBP-1c
    • Ferre P and Foufelle F: Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 12 (Suppl 2): S83-S92, 2010.
    • (2010) Diabetes Obes Metab , vol.12 , pp. S83-S92
    • Ferre, P.1    Foufelle, F.2
  • 31
    • 0027447461 scopus 로고
    • Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers
    • Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K and Wahli W: Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA 90: 2160-2164, 1993.
    • (1993) Proc Natl Acad Sci USA , vol.90 , pp. 2160-2164
    • Keller, H.1    Dreyer, C.2    Medin, J.3    Mahfoudi, A.4    Ozato, K.5    Wahli, W.6
  • 33
    • 0027139820 scopus 로고
    • Peroxisome proliferator-activated receptors A link between endocrinology and nutrition?
    • Keller H and Wahli W: Peroxisome proliferator-activated receptors A link between endocrinology and nutrition? Trends Endocrinol Metab 4: 291-296, 1993.
    • (1993) Trends Endocrinol Metab , vol.4 , pp. 291-296
    • Keller, H.1    Wahli, W.2
  • 35
    • 0030952937 scopus 로고    scopus 로고
    • Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
    • Forman BM, Chen J and Evans RM: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 94: 4312-4317, 1997.
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 4312-4317
    • Forman, B.M.1    Chen, J.2    Evans, R.M.3
  • 38
    • 0036154857 scopus 로고    scopus 로고
    • Control of mitochondrial beta-oxidation flux
    • Eaton S: Control of mitochondrial beta-oxidation flux. Prog Lipid Res 41: 197-239, 2002.
    • (2002) Prog Lipid Res , vol.41 , pp. 197-239
    • Eaton, S.1
  • 39
    • 33845326985 scopus 로고    scopus 로고
    • Peroxisomal beta-oxidation - A metabolic pathway with multiple functions
    • Poirier Y, Antonenkov VD, Glumoff T and Hiltunen JK: Peroxisomal beta-oxidation - a metabolic pathway with multiple functions. Biochim Biophys Acta 1763: 1413-1426, 2006.
    • (2006) Biochim Biophys Acta , vol.1763 , pp. 1413-1426
    • Poirier, Y.1    Antonenkov, V.D.2    Glumoff, T.3    Hiltunen, J.K.4
  • 40
    • 84898439031 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: Molecular mechanisms for the hepatic steatosis
    • Koo SH: Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. Clin Mol Hepatol 19: 210-215, 2013.
    • (2013) Clin Mol Hepatol , vol.19 , pp. 210-215
    • Koo, S.H.1
  • 41
    • 84859157277 scopus 로고    scopus 로고
    • Roles of PPARs in NAFLD: Potential therapeutic targets
    • Tailleux A, Wouters K and Staels B: Roles of PPARs in NAFLD: potential therapeutic targets. Biochim Biophys Acta 1821: 809-818, 2012.
    • (2012) Biochim Biophys Acta , vol.1821 , pp. 809-818
    • Tailleux, A.1    Wouters, K.2    Staels, B.3
  • 42
    • 84863104065 scopus 로고    scopus 로고
    • PPARs at the crossroads of lipid signaling and inflammation
    • Wahli W and Michalik L: PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol Metab 23: 351-363, 2012.
    • (2012) Trends Endocrinol Metab , vol.23 , pp. 351-363
    • Wahli, W.1    Michalik, L.2
  • 43
    • 84924653266 scopus 로고    scopus 로고
    • PPARbeta/delta prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism
    • Salvado L, Barroso E, Gomez-Foix AM, Palomer X, Michalik L, Wahli W and Vázquez-Carrera M: PPARbeta/delta prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism. Diabetologia 57: 2126-2135, 2014.
    • (2014) Diabetologia , vol.57 , pp. 2126-2135
    • Salvado, L.1    Barroso, E.2    Gomez-Foix, A.M.3    Palomer, X.4    Michalik, L.5    Wahli, W.6    Vázquez-Carrera, M.7
  • 45
    • 84929503128 scopus 로고    scopus 로고
    • Activation of peroxisome proliferator activator receptor delta in mouse impacts lipid composition and placental development at early stage of gestation
    • Ding H, Zhang Y, Liu L, Yuan H, Qu J and Shen R: Activation of peroxisome proliferator activator receptor delta in mouse impacts lipid composition and placental development at early stage of gestation. Biol Reprod 91: 57, 2014.
    • (2014) Biol Reprod , vol.91 , pp. 57
    • Ding, H.1    Zhang, Y.2    Liu, L.3    Yuan, H.4    Qu, J.5    Shen, R.6
  • 46
    • 84862009920 scopus 로고    scopus 로고
    • Activation of PPARdelta up-regulates the expression of insulin gene transcription factor MafA and ameliorates glucose-induced insulin secretion impaired by palmitate
    • Cao M, Long Y, Tong Y, Wan J and Tong N: Activation of PPARdelta up-regulates the expression of insulin gene transcription factor MafA and ameliorates glucose-induced insulin secretion impaired by palmitate. Mol Cell Biochem 366: 183-189, 2012.
    • (2012) Mol Cell Biochem , vol.366 , pp. 183-189
    • Cao, M.1    Long, Y.2    Tong, Y.3    Wan, J.4    Tong, N.5
  • 49
    • 84924918447 scopus 로고    scopus 로고
    • Schistosoma japonicum soluble egg antigens facilitate hepatic stellate cell apoptosis by downregulating Akt expression and upregulating p53 and DR5 expression
    • Wang J, Xu F, Zhu D, Duan Y, Chen J, Sun X, He X, Li P, Sun W and Feng J: Schistosoma japonicum soluble egg antigens facilitate hepatic stellate cell apoptosis by downregulating Akt expression and upregulating p53 and DR5 expression. PLoS Negl Trop Dis 8: e3106, 2014.
    • (2014) PLoS Negl Trop Dis , vol.8 , pp. e3106
    • Wang, J.1    Xu, F.2    Zhu, D.3    Duan, Y.4    Chen, J.5    Sun, X.6    He, X.7    Li, P.8    Sun, W.9    Feng, J.10
  • 51
    • 84893146305 scopus 로고    scopus 로고
    • PPARdelta activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preference
    • Feng YZ, Nikolic N, Bakke SS, Boekschoten MV, Kersten S, Kase ET, Rustan AC and Thoresen GH: PPARdelta activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preference. Arch Physiol Biochem 120: 12-21, 2014.
    • (2014) Arch Physiol Biochem , vol.120 , pp. 12-21
    • Feng, Y.Z.1    Nikolic, N.2    Bakke, S.S.3    Boekschoten, M.V.4    Kersten, S.5    Kase, E.T.6    Rustan, A.C.7    Thoresen, G.H.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.